SCHEMBL24323167

SCHEMBL24323167

Cc1cccc(OCc2ccccc2)c1-c1cc(Cl)nc(N)n1

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 6/20 0.56
HSP90AB1 P08238 5/20 0.56
ADCY10 Q96PN6 5/20 0.48
DCPS Q96C86 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
DHFR P00374 2/20 0.44
STAT3 P40763 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
BACE1 P56817 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3946991 0.89 HSP90AA1 (0.74) HSP90AA1HSP90AB1ADCY10DCPSKDM4E
SCHEMBL24298821 0.82 ADCY10 (0.50) HSP90AA1HSP90AB1ADCY10KDM4ESMN1; SMN2
SCHEMBL4213378 0.80 HSP90AA1 (0.70) HSP90AA1HSP90AB1ADCY10
SCHEMBL22501986 0.78 HSP90AA1 (0.66) HSP90AA1HSP90AB1ADCY10KDM4E
SCHEMBL2850401 0.77 BACE1 (0.52) HSP90AA1HSP90AB1ADCY10KDM4EMAPT
Hydrochloric Acid SCHEMBL22502036 0.77 HSP90AA1 (0.64) HSP90AA1HSP90AB1ADCY10KDM4E
SCHEMBL5095747 0.77 BACE1 (0.54) HSP90AA1HSP90AB1KDM4EBACE1
SCHEMBL3943328 0.77 HSP90AA1 (0.60) HSP90AA1HSP90AB1ADCY10DCPSKDM4E
SCHEMBL24323165 0.77 PTGER1 (0.39) MAPTMAPK1TDP1L3MBTL1SMN1; SMN2
SCHEMBL4282091 0.75 AGPAT2 (0.53) HSP90AA1HSP90AB1ADCY10KDM4EBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225765-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 EP disclosed
WO-2022076622-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed
WO-2022076622-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed